We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA approved Takeda Pharmaceutical and Teijin Pharma’s xanthine oxidase inhibitor Uloric for the management of chronically elevated serum uric acid levels in patients with gout.